UK small-cap RNS · 5 Oct 2026
The key announcements of UK small & mid caps under £2bn on 5 Oct 2026 – situations they move are marked, with the share price since.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus director dealings and holdings that are part of a situation. Not investment advice.
| Date | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 5 Oct | EnSilica ENSI | £109m | Transformational contract / build-out | Final Results
The following announcement replaces the "Final Results" announcement released on 5 October 2026 at 07:00 under RNS number 5781X. |
|
| 5 Oct | Milton Capital MII | £0.5m | Results | Unaudited interim results to 31 July 2026
Unaudited interim results for the period ended 31 July 2026 |
|
| 5 Oct | Genflow Biosciences GENF | £10m | Results | Presentation of Interim Results
Presentation of Interim Results from SLAB Canine Study at the Animal Longevity Summit |
|
| 5 Oct | EnSilica ENSI | £109m | Transformational contract / build-out | Final Results
Record FY26 demonstrated the scalability of EnSilica’s business model |